Correlation Between Albireo Pharma and NYSE Composite

Can any of the company-specific risk be diversified away by investing in both Albireo Pharma and NYSE Composite at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Albireo Pharma and NYSE Composite into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Albireo Pharma and NYSE Composite, you can compare the effects of market volatilities on Albireo Pharma and NYSE Composite and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Albireo Pharma with a short position of NYSE Composite. Check out your portfolio center. Please also check ongoing floating volatility patterns of Albireo Pharma and NYSE Composite.

Diversification Opportunities for Albireo Pharma and NYSE Composite

0.1

Correlation Coefficient

Albireo Pharma NYSE Composite

Average diversification

The 3 months correlation between Albireo and NYSE Composite is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Albireo Pharma and NYSE Composite in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NYSE Composite and Albireo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Albireo Pharma are associated (or correlated) with NYSE Composite. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NYSE Composite has no effect on the direction of Albireo Pharma i.e., Albireo Pharma and NYSE Composite go up and down completely randomly.

Pair Corralation between Albireo Pharma and NYSE Composite

Given the investment horizon of 90 days Albireo Pharma is expected to generate 14.26 times more return on investment than NYSE Composite. However, Albireo Pharma is 14.26 times more volatile than NYSE Composite. It trades about 0.17 of its potential returns per unit of risk. NYSE Composite is currently generating about -0.01 per unit of risk. If you would invest  1,997  in Albireo Pharma on December 22, 2022 and sell it today you would earn a total of  2,418  from holding Albireo Pharma or generate 121.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	80.0%
Values	Daily Returns

Albireo Pharma  vs.  NYSE Composite

Pair Trading with Albireo Pharma and NYSE Composite

The main advantage of trading using opposite Albireo Pharma and NYSE Composite positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Albireo Pharma position performs unexpectedly, NYSE Composite can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NYSE Composite will offset losses from the drop in NYSE Composite's long position.

	Albireo Pharma vs. Definitive Healthcare Corp
	Albireo Pharma vs. NTT DATA
	Albireo Pharma vs. Agiliti
	Albireo Pharma vs. FactSet Research Systems

The idea behind Albireo Pharma and NYSE Composite pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

	NYSE Composite vs. T-Mobile US
	NYSE Composite vs. KVH Industries
	NYSE Composite vs. Mondee Holdings
	NYSE Composite vs. Direct Communication Solutions

Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.